Are you a young start-up (<8 years) or an academic researcher who wants more visibility and professional feedback on your running project?Are you implemented in the development of an innovative drug, medical device, application, or technology that serves the needs for diagnostics, therapeutics or E-Health within Life Sciences?Are you ready to share your passion for innovation ? Join the Innovation Prize and become the most innovative 2015 global project Win up to €30 000 including cash and consulting servicesIncrease your visibility within the healthcare industryGet the feedback from a jury of experts of the pharmaceutical and biotechnological sectorsParticipate in the 6th edition of the Innovation Days Questions or remarks?Email or call us and follow us on LinkedIn, Twitter and our website to stay up-to-date! You can also click on the button to the left and discover the Innovation Prize Trailer! Innovation Prize 2015 TeamInnovation Prize Manager jeremy.berthuin@universalmedica.com +33 (0) 1 41 12 27 87 Innovation Prize Manager dieter.deryckere@universalmedica.com +33 (0) 1 41 12 27 92

L'association a pour but de promouvoir le développement de l’industrie des biotechnologies et des sciences de la vie en France

The following candidates had their projects introduced during the Innovation Prize. Discover how far they’ve developped since then. Participate in the Innovation Prize 2015 and boost your project’s chances! Open to young start-ups (less than 8 years of existence) and academic lab developing solutions for the healthcare industry, the Universal Biotech Innovation Prize aims to acknowledge on an international scale, the most innovative early stage

Why participate in the Innovation Prize? – A prize up to €60 000 including cash and consulting services – Increase your visibility within the healthcare industry – Get the feedback from a jury of experts of the pharmaceutical and biotechnological sectors – Participate in the 6th edition of the Innovation Days (more information here) – Improve your business plan *: young start-ups with less than

Roche, dont les résultats ont été publiés le 28 janvier, a racheté cette pépite en 2010. Le laboratoire est aujourd’hui le numéro un mondial des biotechnologies.